Examination of factors affecting quality of life, physical activity level, cognitive impairment, and dyspnea level in individuals with long COVID: A cross-sectional study

Fatma Eken; Emel Taşvuran Horata; Mine Arğalı Deniz; Aydın Balcı

doi:10.26900/hsq.2564

Authors

Fatma Eken Afyonkarahisar Health Sciences University / Türkiye https://orcid.org/0000-0003-2975-7480
Emel Taşvuran Horata Sakarya University of Applied Sciences / Türkiye https://orcid.org/0000-0002-2471-3713
Mine Arğalı Deniz Süleyman Demirel University Research and Application Hospital / Türkiye https://orcid.org/0000-0001-8055-9530
Aydın Balcı Afyonkarahisar Health Sciences University / Türkiye https://orcid.org/0000-0002-6723-2418

DOI:

https://doi.org/10.26900/hsq.2564

Keywords:

Chronic Long COVID, subjective health, disease burden, post-COVID conditions

Abstract

It is known that COVID-19, which affects large masses worldwide, causes prolonged symptoms in some individuals. The present study aims to determine the factors affecting quality of life, physical activity level, cognitive impairment, and dyspnea level in individuals with long COVID. The study included COVID-19 patients diagnosed at the Chest Diseases Clinic at least 12 weeks ago. Phone calls were conducted to all participants to collect demographic and clinical data. Participants were verbally administered the modified Medical Research Council (mMRC) dyspnea scale, International Physical Activity Questionnaire (Short Form), EQ-5D-5L Scale, and Short Blessed Orientation-Memory-Concentration test (BOMC). Multiple linear regression was used to determine independent variable effects on dependent variables. The study included 176 individuals, with a mean age of 54.57±1.49 years and 41.5% (73) being female. Female gender (0.112 times), severe disease (0.282 times), and aging (0.006 units per year) were found to impact quality of life negatively (p<0.05). Females (330.068 times) and older individuals (14.711 times) had lower physical activity levels (p<0.05). A one-year increase in age increased the cognitive impairment level by 0.181 units. Moderate and severe disease increased cognitive impairment by 3.509 and 5.764 times, respectively, compared to mild disease. Dyspnea increased with age (0.031 units) and severity (0.446 times intermediate disease; 0.981 times severe disease). The physical and cognitive evaluation of individuals with long COVID, especially those of female gender and advanced age and with severe disease, is important for their activities of daily living and quality of life.

Downloads

Download data is not yet available.

References

Mahase E. Covid-19: What do we know about “long covid?” BMJ (Clinical research ed). 2020;370:m2815. doi: 10.1136/bmj.m2815.

Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621.

Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis. J Clin Med. 2022;11(24):7314. doi: 10.3390/jcm11247314.

Baig AM. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555-6. doi: 10.1002/jmv.26624.

Halpin S, O'Connor R, Sivan M. Long COVID and chronic COVID syndromes. J Med Virol. 2021;93(3):1242. doi: 10.1002/jmv.26587.

Parotto M, Gyöngyösi M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, et al. Post-acute sequelae of COVID-19: Understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739-54. doi: 10.1016/S2213-2600(23)00239-4.

National Institute for Health and Care Excellence (NICE): Clinical Guidelines. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence; 2020. Retrieved from: https://www.nice.org.uk/guidance/ng188. (Accessed on Feb 16, 2025)

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46. doi: 10.1038/s41579-023-00896-0.

Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629.

van Kessel SA, Olde Hartman TC, Lucassen PL, van Jaarsveld CH. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam Pract. 2022;39(1):159-67. doi: 10.1093/fampra/cmab076.

Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378-83. doi: 10.1016/j.jinf.2021.01.004.

Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.

Nielsen TB, Leth S, Pedersen M, Harbo HD, Nielsen CV, Laursen CH, et al. Mental fatigue, activities of daily living, sick leave and functional status among patients with long COVID: A cross-sectional study. Int J Environ Res Public Health. 2022;19(22):14739. doi: 10.3390/ijerph192214739.

Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. 2022;101(1):48. doi: 10.1097/PHM.0000000000001910.

Larsson AC, Palstam A, Persson HC. Physical function, cognitive function, and daily activities in patients hospitalized due to COVID-19: A descriptive cross-sectional study in Sweden. Int J Environ Res Public Health. 2021;18(21):11600. doi: 10.3390/ijerph182111600.

Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post‐COVID‐19 manifestations. Int J Clin Pract. 2021;75(3):e13746. doi: 10.1111/ijcp.13746.

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-6. doi: 10.1136/thx.54.7.581.

Savcı S, Öztürk M, Arıkan H, İnal İnce D, Tokgözoğlu L. Physical activity levels of university students. Arch Turk Soc Cardiol. 2006;34(3):166-72. Retrieved from: https://www.archivestsc.com/jvi.aspx?pdir=tkd&plng=eng&un=TKDA-46330&look4=#. (Accessed on Feb 14, 2025)

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727-36. doi: 10.1007/s11136-011-9903-x.

Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140(6):734-9. doi: 10.1176/ajp.140.6.734.

George D, Mallery P. IBM SPSS statistics 27 step by step: A simple guide and reference: Routledge; 2021. doi: 10.4324/9781003205333.

Cohen J. Statistical power analysis for the behavioral sciences: Academic press; 2013. doi: 10.4324/9780203771587.

Field A. Discovering statistics using IBM SPSS statistics: Sage; 2013. Retrieved from: https://sadbhavnapublications.org/research-enrichment-material/2-Statistical-Books/Discovering-Statistics-Using-IBM-SPSS-Statistics-4th-c2013-Andy-Field.pdf. (Accessed on Feb 16, 2025)

Gunnarsson DV, Miskowiak KW, Pedersen JK, Hansen H, Podlekareva D, Johnsen S, et al. Physical function and association with cognitive function in patients in a post-COVID-19 clinic-A cross-sectional study. Int J Environ Res Public Health. 2023;20(10):5866. doi: 10.3390/ijerph20105866.

Thurner C, Stengel A. Long-COVID syndrome: Physical–mental interplay in the spotlight. Inflammopharmacology. 2023;31(2):559-64. doi: 10.1007/s10787-023-01174-4.

Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortuño R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med. 2021;10(24):5913. doi: 10.3390/jcm10245913.

Björkdahl A, Gustafsson M, Öhlén H, Jarl S, Santos Tavares Silva I. Exploring the impact of cognitive dysfunction, fatigue, and shortness of breath on activities of daily life after COVID-19 infection, until 1-year follow-up. J Rehabil Med. 2024;25:56:jrm35403. doi: 10.2340/jrm.v56.35403.

Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: A review. J R Soc Med. 2021;114(9):428-42. doi: 10.1177/01410768211032850.

Lin YN, Liu ZR, Li SQ, Li CX, Zhang L, Li N, et al. Burden of sleep disturbance during COVID-19 pandemic: A systematic review. Nat Sci Sleep. 2021;933-66. doi: 10.2147/NSS.S312037.

Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055-68. doi: 10.1183/09031936.00059814.

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. doi: 10.1038/s41591-021-01361-2.

Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0.

McFann K, Baxter BA, LaVergne SM, Stromberg S, Berry K, Tipton M, et al. Quality of Life (QoL) is reduced in those with severe COVID-19 disease, post-acute sequelae of COVID-19, and hospitalization in United States adults from Northern Colorado. Int J Environ Res Public Health. 2021;18(21):11048. doi: 10.3390/ijerph182111048.

Todt BC, Szlejf C, Duim E, Linhares AO, Kogiso D, Varela G, et al. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir Med. 2021;184:106453. doi: 10.1016/j.rmed.2021.106453.

Pappa S, Barmparessou Z, Athanasiou N, Sakka E, Eleftheriou K, Patrinos S, et al. Depression, insomnia and post-traumatic stress disorder in COVID-19 survivors: Role of gender and impact on quality of life. J Pers Med. 2022;12(3):486. doi: 10.3390/jpm12030486.

Lemhöfer C, Sturm C, Loudovici-Krug D, Guntenbrunner C, Bülow M, Reuken P, et al. Quality of life and ability to work of patients with Post-COVID syndrome in relation to the number of existing symptoms and the duration since infection up to 12 months: A cross-sectional study. Qual Life Res. 2023;1-12. doi: 10.1007/s11136-023-03369-2.

Rosa RG, Cavalcanti AB, Azevedo LCP, Veiga VC, de Souza D, Dos Santos RdRM, et al. Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study. Intensive Care Med. 2023;49(2):166-77. doi: 10.1007/s00134-022-06953-1.

Gautam N, Madathil S, Tahani N, Bolton S, Parekh D, Stockley J, et al. Medium-Term outcomes in severely to critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2022;74(2):301-8. doi: 10.1093/cid/ciab341.

Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9-611.e16. doi: 10.1016/j.cmi.2021.11.002.

Pelà G, Goldoni M, Solinas E, Cavalli C, Tagliaferri S, Ranzieri S, et al. Sex-related differences in long-COVID-19 syndrome. J Womens Health. 2022;31(5):620-30. doi: 10.1089/jwh.2021.0411.

Fernández-de-Las-Peñas C, Martín-Guerrero JD, Florencio LL, Navarro-Pardo E, Rodríguez-Jiménez J, Torres-Macho J, et al. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2023;51(1):61-9. doi: 10.1007/s15010-022-01822-x.

Paradowska-Nowakowska E, Łoboda D, Gołba KS, Sarecka-Hujar B. Long COVID-19 Syndrome severity according to sex, time from the onset of the disease, and exercise capacity - The results of a cross-sectional study. Life. 2023;13(2):508. doi: 10.3390/life13020508.

Juszko K, Szary P, Mazurek J, Rutkowski S, Cieślik B, Szczepańska-Gieracha J, et al. Long-term consequences of COVID-19 Disease specific to women: Exploratory research. Int J Environ Res Public Health. 2022;20(1):150. doi: 10.3390/ijerph20010150.

Lindahl A, Aro M, Reijula J, Mäkelä MJ, Ollgren J, Puolanne M, et al. Women report more symptoms and impaired quality of life: A survey of Finnish COVID-19 survivors. Infect Dis. 2022;54(1):53-62. doi: 10.1080/23744235.2021.1965210.

Jensen A, Castro AW, Ferretti MT, Martinkova J, Vasilevskaya A, Chadha, et al. Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: a narrative review. Ital J Gender-Specific Med. 2022;8(1):18-28. doi 10.1723/3769.37563.

Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K.The influence of gender and other patient characteristics on health care-seeking behaviour: A QUALICOPC study. BMC Fam Pract. 2016;17:1-7. doi: 10.1186/s12875-016-0440-0.

O’Neil A, Russell JD, Thompson K, Martinson ML, Peters SA. The impact of socioeconomic position (SEP) on women's health over the lifetime. Maturitas. 2020;140:1-7. doi: 10.1016/j.maturitas.2020.06.001.

Sojka A, Machniak M, Andrzejewski W, Kosendiak A, Chwałczyńska A. Changes in physical activity and the occurrence of specific symptoms of “long-COVID syndrome” in men aged 18–25. Int J Environ Res Public Health. 2022;19(3):1199. doi: 10.3390/ijerph19031199.

Güneş M, Yana M, Güçlü MB. Physical activity levels respiratory and peripheral muscle strength and pulmonary function in young post-COVID-19 patients: A cross-sectional study. Wien Klin Wochenschr. 2023;1-9. doi: 10.1007/s00508-023-02204-5.

Shanbehzadeh S, Zanjari N, Yassin M, Yassin Z, Tavahomi M. Association between long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023;23(1):40. doi: 10.1186/s12877-023-03757-w.

de Maio Nascimento M, Gouveia BR, Gouveia ÉR, Campos P, Marques A, Ihle A. Muscle strength and balance as mediators in the association between physical activity and health-related quality of life in community-dwelling older adults. J Clin Med. 2022;11(16):4857. doi: 10.3390/jcm11164857.

Li T, Sun S, Liu B, Wang J, Zhang Y, Gong C, et al. Prevalence and risk factors for anxiety and depression in patients with COVID-19 in Wuhan, China. Psychosom Med. 2021;83(4):368-72. doi: 10.1097/PSY.0000000000000934.

Rudroff T, Workman CD, Bryant AD. Potential factors that contribute to post-COVID-19 fatigue in women. Brain Sci. 2022;12(5):556. doi: 10.3390/brainsci12050556.

Jimeno-Almazán A, Martínez-Cava A, Buendía-Romero Á, Franco-López F, Sánchez-Agar JA, Sánchez-Alcaraz BJ, et al. Relationship between the severity of persistent symptoms, physical fitness, and cardiopulmonary function in post-COVID-19 condition. A population-based analysis. Intern Emerg Med. 2022;17(8):2199-208. doi: 10.1007/s11739-022-03089-4.

Zheng B, Vivaldi G, Daines L, Leavy OC, Richardson M, Elneima O, et al. Determinants of recovery from post-COVID-19 dyspnoea: Analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. Lancet Reg Health Eur. 2023;28(29):100635. doi: 10.1016/j.lanepe.2023.100635.

Cecchetto A, Guarnieri G, Torreggiani G, Vianello A, Baroni G, Palermo C, et al. Dyspnea in post-acute COVID-19: A multi-parametric cardiopulmonary evaluation. J Clin Med. 2023;12(14):4658. doi: 10.3390/jcm12144658.

Li Z, Zhang Z, Zhang Z, Wang Z, Li H. Cognitive impairment after long COVID-19: current evidence and perspectives. Front Neurol. 2023;14:1239182. doi: 10.3389/fneur.2023.1239182.

Manganotti P, Michelutti M, Furlanis G, Deodato M, Buoite Stella A.Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment. Clin Neurophysiol. 2023;151:83-91. doi: 10.1016/j.clinph.2023.04.010.

Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27(3):421-432. doi: 10.1038/s41593-024-01576-9.

Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment - A review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12(4):840-51. doi: 10.1016/j.arr.2013.06.004.

Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018;144(2):115-26. doi: 10.1001/jamaoto.2017.2513.

Nouraeinejad A. Brain fog as a long-term sequela of COVID-19. SN Compr Clin Med. 2022;5(1):9. doi: 10.1007/s42399-022-01352-5.

Houben S, Bonnechère B. The impact of COVID-19 infection on cognitive function and the implication for rehabilitation: A systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(13):7748. doi: 10.3390/ijerph19137748.

Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J, et al. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39-48. doi: 10.1016/j.euroneuro.2021.03.019.

Liu Y-H, Wang Y-R, Wang Q-H, Chen Y, Chen X, Li Y, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16:1-10. doi: 10.1186/s13024-021-00469-w.